Recognition of exposed phosphatidylserine on apoptotic cells is critical for their removal. A recent study suggests that annexin I is also externalized on apoptotic cells and may enhance phagocytosis of dying cells through the phosphatidylserine receptor. Following these data supporting a role for annexin I bridging PS on apoptotic cells to phagocytes, Arur and colleagues [12] then closed the loop by suggesting involvement of the PS receptor in this uptake pathway. Immunofluorescence studies revealed that the PS receptor on phagocytes appeared to cluster around the dying cell; this clustering was reduced when the apoptotic cells had been silenced for annexin I expression using siRNA.
bind have not yet been identified. GAS-6 is a ligand for the receptor tyrosine kinase MER, reported to be involved in engulfment of apoptotic cells [10] , whereas MFG-E8 is believed to bind to α αvβ β3 [9] , the vitronectin receptor implicated in the recognition and uptake of apoptotic cells many years ago by Savill and colleagues [11] . A few years ago, Reutlingsperger posed the hypothesis that annexins might also serve to bridge apoptotic cells to hungry phagocytes (C. Reutlingsperger, personal communication). Now, a recent paper from Arur and colleagues [12] supports that hypothesis and adds a twist to the story: that annexin I may serve to facilitate or enhance the recognition of PS by the PS receptor.
Using a quantitative proteomics approach, Arur et al. [12] compared membranes from normal and apoptotic cells. They found that expression of annexin I protein was elevated in membranes from dying cells compared with viable cells. While no annexin I could be detected by immunofluorescence on the surface of viable cells, apoptotic cells appeared to express this protein in patches, reminiscent of the way in which exogenously applied annexin V binds to exposed PS on dying cells. Permeabilization of the cells showed that annexin I was recruited to the membrane early in apoptosis before its accumulation on the cell surface. These findings were confirmed by cell fractionation and western blotting. The translocation of annexin I appeared to require activation of caspases as well as an increase in intracellular calcium levels, but the mechanism by which the protein is translocated across the membrane remains mysterious. It is interesting to note, however, that the ATP-binding cassette transporter A1 (ABC A1), implicated in the recognition and uptake of apoptotic cells by macrophages [13] , has also been linked to the externalization of annexin I in pituitary folliculo-stellate cells [14] .
A role for annexin I in uptake was confirmed by the use of small interfering RNAs to reduce annexin I expression in the dying cells. The efficiency of engulfment of these cells was reduced by approximately 60%. Uptake of these annexin I-silenced apoptotic cells was restored by adding exogenous annexin I, further supporting a role for this protein in clearance. Downregulation of the expression of the nematode annexin I homologue, nex-I, impaired engulfment of apoptotic cellular corpses in C. elegans as well, supporting the idea of phylogenetic conservation of this uptake pathway.
Following these data supporting a role for annexin I bridging PS on apoptotic cells to phagocytes, Arur and colleagues [12] then closed the loop by suggesting involvement of the PS receptor in this uptake pathway. Immunofluorescence studies revealed that the PS receptor on phagocytes appeared to cluster around the dying cell; this clustering was reduced when the apoptotic cells had been silenced for annexin I expression using siRNA. A third question concerns how annexin I bound to the external surface of apoptotic cells facilitates uptake in the face of the known ability of exogenously added annexin V to block uptake. The answer may relate to differences in thermodynamic properties between the two proteins contributing to different functions [15] . How PS in a cell membrane binds to both these annexins as well as how it binds to the PSR need to be clarified. Confirming a role for these molecules in vivo remains a critical goal.
Why are there so many PS-binding proteins that may be involved in phagocyte recognition of apoptotic cells? In general, the dogma is that apoptotic cells are anti-inflammatory. However, there are some scenarios in which they have been shown to be proinflammatory or proimmunogenic [16, 17] , particularly when used to stimulate immunity against tumours (for example, see [18] [19] [20] ). Leaving out technical issues associated with purity of apoptotic cell populations and content of necrotic cells, these contrasting effects raise some interesting possibilities. Do some of the PS-binding proteins in fact block the anti-inflammatory effects of PS? If so, the true effects of the apoptotic cell on inflammation and immune response will be determined by how much PS is bound by these various proteins in vivo versus how much is free, and whether these proteins trigger anti-inflammatory or proinflammatory receptors on phagocytes. 
